Navigation Links
Harnessing anticancer drugs for the future fight against influenza
Date:9/5/2012

Medical Systems Virology group at the Institute for Molecular Medicine Finland (FIMM) at the University of Helsinki, together with its national and international collaborators, developed a new cell screening method that can be used to identify potential anti-influenza drugs. The researchers were able to identify two novel compounds with anti-influenza activity, obatoclax and gemcitabine and prove the efficacy of a previously known drug saliphenylhalamide.

The study was recently accepted for publication in the Journal of Biological Chemistry and is now available online.

Influenza viruses cause significant human morbidity and mortality. To treat the infections, different virus-directed drugs have been developed. However, the currently available drugs are targeting viral proteins and due to a high mutation rate the influenza viruses quickly develop resistance to them. For that reason, next-generation antiviral drugs should be directed towards the host functions. The results of this study provide a foundation for development of next-generation antiviral drugs. Furthermore, these identified compounds can be used as chemical tools when studying the molecular mechanisms of virus-host interactions.

"An interesting aspect of this study is that the antiviral effects of obatoclax, saliphenylhalamide and gemcitabine, which all are either investigational or approved anticancer agents, are achieved at much lower concentrations than that needed to mediate cancer cell death" said the group leader Denis Kainov.

However, further research is still needed before these drugs can be clinically tested and applied in influenza infections.

This research project is a good example of repurposing of drugs, i.e. finding new applications for existing drugs and thus saving money and time on drug development.

"We anticipate that these types of drugs could in the future reinforce the therapeutic arsenal and address the need
'/>"/>

Contact: Dr. Laura Kakkola
laura.kakkola@fimm.fi
358-503-112-552
University of Helsinki
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Harnessing the Materials Genome Conference
2. A new vision for harnessing data about life on Earth
3. High levels of TRAIL protein in breast milk might contribute to anticancer activity
4. Chemicals today, drugs tomorrow: U-Ms new Center for Drug Discovery
5. Target for potent first-strike influenza drugs identified
6. 3-D motion of cold virus offers hope for improved drugs using Australias fastest supercomputer
7. Single protein promotes resistance to widely used anti-estrogen drugs
8. Efforts to develop new drugs that hopefully will never be used
9. Arsenic for better drugs and cleaner crops
10. MIT-designed cooler preserves tuberculosis drugs, records doses
11. La Jolla Institute discovery could lead to new way to screen drugs for adverse reactions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Harnessing anticancer drugs for the future fight against influenza
(Date:7/10/2014)... New York , July 7, 2014 ... by Transparency Market Research "Electronic Access Control Systems Market ... 2014 - 2019," the global Electronic Access Control systems ... and is expected to grow at a CAGR of ... value of USD 31,187.8 million in 2019. ...
(Date:7/10/2014)... belongs to the large, mainly tropical flowering plant family ... in the family rely on bees for their pollination. Only ... or vertebrates. The flowers of Axinaea appear in ... petals of the different species are pink, yellow, orange or ... the contrasting colours of their bulbous appendages. The pollination mechanism ...
(Date:7/10/2014)... has helped stabilize or even improve the state ... the situation in the Mediterranean has deteriorated over ... evaluating nine fish species reported in the Cell ... 10, scientists call for stringent monitoring of Mediterranean ... advanced management plans in Mediterranean waters. , Their ...
Breaking Biology News(10 mins):Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 2Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 3Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 4Electronic Access Control Systems Market is Expected to Reach USD 31.2 Billion Globally in 2019: Transparency Market Research 5Novel type of bird pollination mechanism discovered in South America 2Mediterranean fish stocks show steady decline 2
... 20, 2013 Market news updates for advancing ... Inc. (OTCQB: NXTD), Apple Inc. (NASDAQ: AAPL ), ... CSCO ) and NQ Mobile Inc. (NYSE: NQ) ... published a report on NXT-ID, Inc., (OTCQB: NXTD) featuring the ...
... of all humans are persistently colonized with Staphylococcus aureus ... of the major sources of hospital-acquired infections, including the antibiotic-resistant ... discovered one of the keys to the immense success of ... immune defense mechanism and use it to destroy white blood ...
... fattening than others? What about the risks of bariatric ... (ASN) on December 5-7 for answers to these questions ... Nutrition Conference. The 3-day program delivers valuable ... satellite sessions, and networking opportunities. Credentialed media, science writers ...
Cached Biology News:Biometric-Mobile Wallet Technology Takes Aims at a Target Market Of Nearly $1Billion Potential 2Biometric-Mobile Wallet Technology Takes Aims at a Target Market Of Nearly $1Billion Potential 3Biometric-Mobile Wallet Technology Takes Aims at a Target Market Of Nearly $1Billion Potential 4Biometric-Mobile Wallet Technology Takes Aims at a Target Market Of Nearly $1Billion Potential 5Staphylococcus aureus bacteria turns immune system against itself 2Advances and Controversies in Clinical Nutrition: Diet, Technology and Practice 2
(Date:7/10/2014)... Hall effect in bilayer graphene and shown that this ... electric field. , The fractional quantum Hall effect, ... are exposed to large magnetic fields, is a striking ... behave as a single system. However, while the basic ... of this collective behavior remain not well understood, in ...
(Date:7/10/2014)... out for crude 3-D glasses, polarized glasses, and ... basic devices, used to trick the brain into ... rendered obsolete with the introduction of new holography ... TAU doctoral students Yuval Yifat, Michal Eitan, and ... on nanoantennas that could be used for security ...
(Date:1/15/2014)... assembling a club sandwich at the nanoscale, National ... succeeded in crafting a uniform, multi-walled carbon-nanotube-based coating ... used in upholstered furniture and other soft furnishings. ... was reduced 35 percent compared with untreated foam. ...
(Date:1/15/2014)... PA (PRWEB) January 15, 2014 The Pittcon ... publisher of Food Safety Tech , an e-Journal and ... signed an agreement for the second year for the co-location ... Pittcon 2014. The partnership provides that the registration fee to ...
Breaking Biology Technology:Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3Projecting a 3-dimensional future 2Projecting a 3-dimensional future 3Layered security: Carbon nanotubes promise improved flame-resistant coating 2Pittcon Announces Second Year Partnership With Food Safety Tech 2Pittcon Announces Second Year Partnership With Food Safety Tech 3
... Disease Altering Treatment Shows Ability to Prevent HIV ... VIRxSYS Corporation, a,privately held company developing gene therapies ... Phase II trial of VRX496, a gene,therapy for ... Conference on,Retroviruses and Opportunistic Infections (CROI) in Boston, ...
... Strengthening PPD,s presence in Eastern Europe, WILMINGTON, N.C., ... has signed an agreement to purchase InnoPharm,Ltd., an independent ... acquisition will expand PPD,s global reach with,established offices in ... CROs in Russia, InnoPharm was a pioneer in the,implementation ...
... (Nasdaq: IDIX ) announced today that Idenix management,will ... & Investor,Conference on Tuesday, February 12, 2008 at 9:30 ... the Waldorf-Astoria Hotel in New York, NY., The ... accessed,under "Calendar of Events" in the Idenix Investor Center ...
Cached Biology Technology:VIRxSYS Announces Interim Results from VRX496 Gene Therapy Phase II Trial 2PPD to Acquire InnoPharm Ltd. 2PPD to Acquire InnoPharm Ltd. 3
...
... Antibody Validation Service enables early selection ... development by providing quantitative data for ... of each antibody. Furthermore quantitative antibody ... off-target activity of your antibodies., The ...
... western blotting. Get results sooner and save hours ... detection. Eliminates the need for a membrane transfer ... reagents are ready-to-use. No reagents to prepare or ... reagents required. Guarantees a simple to perform, mistake-free ...
... paper sandwiches are composed of a precut ... thick filter paper that are preassembled into ... These 7 x 8.5 cm membrane sandwiches ... Gel-sized gels and are supplied as a ...
Biology Products: